期刊论文详细信息
Innovations in Clinical Neuroscience | |
Attention Deficit Hyperactivity Disorder Subtypes and Symptom Response in Adults Treated with Lisdexamfetamine Dimesylate | |
Brian Scheckner1  Greg Mattingly1  Robert Lasser1  Ben Adeyi1  Bryan Dirks1  Thomas Babcock1  Richard Weisler1  | |
[1] Dr. Mattingly is from Washington University School of Medicine in St. Charles, Missouri; Dr. Weisler is from Duke University Medical Center in Durham, North Carolina, and the University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; Drs. Dirks, Babcock Scheckner, and Lasser and Mr. Adeyi are from Shire Development LLC, Wayne, Pennsylvania. | |
关键词: Lisdexamfetamine dimesylate (LDX); attention-deficit/hyperactivity disorder (ADHD); adults; ADHD-RS-IV symptom subtype; amphetamine; stimulant; predominantly inattention; predominantly hyperactivity/impulsivity; predominantly combined; clinical response; | |
DOI : | |
学科分类:精神健康和精神病学 | |
来源: Matrix Medical Communications, LLC | |
【 摘 要 】
Objective: To evaluate the efficacy of lisdexamfetamine dimesylate in adults with attention deficit hyperactivity disorder symptom subtypes who exhibit predominantly inattention, hyperactivity/ impulsivity, or combined symptom clusters.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201912040560680ZK.pdf | 198KB | download |